KAM-18419-43481
4 vaccinations
2 coded responses
21 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 945 / CA
- Registered
- 2022-06-15
- Relationship
- Child or adolescent in my care
- Guardian
- 6C3-22783-04472
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-05
Dose 1 — Pfizer-BioNTechCo-administered: Flu
-
2021-12-01
Dose 2 — Pfizer-BioNTech
-
2022-06-03
Dose 3 — Pfizer-BioNTech
-
2022-06-15
Registered in v-safe
- 2022-06-15
- 2022-06-20
- 2022-06-24
- 2022-07-01
- 2022-07-08
- 2022-07-15
- 2022-09-02
-
2022-11-09
Dose 4 — Moderna
-
2022-11-10
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness, DiarrheaAdult check-in
- 2022-11-11
- 2022-11-12
- 2022-11-13
- 2022-11-14
- 2022-11-15
- 2022-11-16
-
2022-11-23
Survey response — day 14, dose 4, dependentMedDRA: Oropharyngeal pain, Sinus congestion — Feeling: GoodFree text: Mild sore throat and sinus congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-30
Survey response — day 21, dose 4, dependentMedDRA: Hand-foot-and-mouth disease — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Hand foot and mouth diseaseMedDRA releases: 2024-11 · check-in free text available
-
2022-11-30
Report sent to call center — day 21, dose 4, dependentBe unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-01
-
2022-12-01
Call successfulDoes not wish to fill out VAERS report
- 2022-12-07
- 2022-12-14
- 2022-12-21
- 2023-02-08
- 2023-05-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-05 | Pfizer-BioNTech | Flu |
| 2 | 2021-12-01 | Pfizer-BioNTech | No |
| 3 | 2022-06-03 | Pfizer-BioNTech | No |
| 4 | 2022-11-09 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-30 | Successful 2022-12-01 |
Does not wish to fill out VAERS report |
Free text
Release 12 — day 14, dose 4, dependent
Symptoms: Mild sore throat and sinus congestion
Release 12 — day 21, dose 4, dependent
Symptoms: Hand foot and mouth disease
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release